Body weight and fat-free mass changes in a cohort of patients receiving chemotherapy
- PMID: 19621246
- DOI: 10.1007/s00520-009-0703-6
Body weight and fat-free mass changes in a cohort of patients receiving chemotherapy
Abstract
Purpose: Malnutrition is prevalent in cancer patients and it can become even greater during its treatment. The purpose of the present study is to verify changes in the fat-free mass (FFM) and body weight (BW) in cancer patients during chemotherapy treatment and to identify their significant determinants.
Methods: In a longitudinal study of 174 patients starting a chemotherapy protocol, bioelectrical impedance analysis (BIA) was used to estimate FFM and the nutritional assessment by patient-generated subjective global assessment. BW and FFM changes have been calculated and their significant determinants were identified after a multivariate analysis.
Results: Malnutrition was found in 23% of the patients at the admission. After a multivariate analysis, a significant BW change was found during the treatment in patients submitted to previous/adjuvant and palliative chemotherapy (weight gain of 4.15% and 2.23%, respectively, p = 0.05) and a significant FFM loss (7.61%, p < 0.01) in patients with severe malnutrition at admission.
Conclusions: Only the chemotherapy protocol and initial nutritional state had a significant influence in BW and FFM changes during the chemotherapy. BIA may contribute to other methods of nutritional assessment, in order to detect modifications in body composition even in the absence of BW changes.
Similar articles
-
Bioelectrical impedance vector analysis as a useful predictor of nutritional status in patients with short bowel syndrome.Clin Nutr. 2017 Aug;36(4):1117-1121. doi: 10.1016/j.clnu.2016.07.011. Epub 2016 Jul 27. Clin Nutr. 2017. PMID: 27491548
-
Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques.Eur J Nutr. 2009 Aug;48(5):315-22. doi: 10.1007/s00394-009-0017-y. Epub 2009 Mar 31. Eur J Nutr. 2009. PMID: 19333642
-
A comparison of the malnutrition screening tools, MUST, MNA and bioelectrical impedance assessment in frail older hospital patients.Clin Nutr. 2015 Apr;34(2):296-301. doi: 10.1016/j.clnu.2014.04.013. Epub 2014 May 2. Clin Nutr. 2015. PMID: 24835154
-
The Clinical Value of Nutritional Care before and during Active Cancer Treatment.Nutrients. 2021 Apr 5;13(4):1196. doi: 10.3390/nu13041196. Nutrients. 2021. PMID: 33916385 Free PMC article. Review.
-
Should calculation of chemotherapy dosage for bowel cancer be based on body composition?Tidsskr Nor Laegeforen. 2020 May 19;140(8). doi: 10.4045/tidsskr.19.0769. Print 2020 May 26. Tidsskr Nor Laegeforen. 2020. PMID: 32463187 English, Norwegian.
Cited by
-
The relationship between nutritional status and handgrip strength in adult cancer patients: a cross-sectional study.Support Care Cancer. 2018 Jul;26(7):2441-2451. doi: 10.1007/s00520-018-4082-8. Epub 2018 Feb 9. Support Care Cancer. 2018. PMID: 29427194
-
Optimization of nutrition support practices early after hematopoietic cell transplantation.Bone Marrow Transplant. 2021 Feb;56(2):314-326. doi: 10.1038/s41409-020-01078-9. Epub 2020 Oct 10. Bone Marrow Transplant. 2021. PMID: 33040076 Review.
-
The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients--a comprehensive review.Eur J Clin Nutr. 2015 Dec;69(12):1290-7. doi: 10.1038/ejcn.2015.126. Epub 2015 Jul 29. Eur J Clin Nutr. 2015. PMID: 26220573 Review.
-
HALP score and GNRI: Simple and easily accessible indexes for predicting prognosis in advanced stage NSCLC patients. The İzmir oncology group (IZOG) study.Front Nutr. 2022 Aug 18;9:905292. doi: 10.3389/fnut.2022.905292. eCollection 2022. Front Nutr. 2022. PMID: 36061883 Free PMC article.
-
Clinical utility of bioelectrical impedance analysis in patients with locoregional muscle invasive or metastatic urothelial carcinoma: a subanalysis of changes in body composition during neoadjuvant systemic chemotherapy.Support Care Cancer. 2018 Apr;26(4):1077-1086. doi: 10.1007/s00520-017-3924-0. Epub 2017 Oct 11. Support Care Cancer. 2018. PMID: 29022158
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical